Ritedose Pharmaceuticals Continues Tradition of Giving Back – Increases its Annual Donation to Unprecedented Amount of 1 Million Doses of Respiratory Medications to Dispensary of Hope for Low-income and Chronically lll Patients

– In 2023, Ritedose Pharmaceuticals donated more than 77,760 doses of Ipratropium Bromide* and 46,800 doses of Levalbuterol Inhalation Solution*. COLUMBIA, S.C., Aug. 12, 2024 /PRNewswire/ — Ritedose Pharmaceuticals, a division of The Ritedose Corporation (Ritedose), the leading contract…